BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36735909)

  • 1. The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53.
    Piqué-Borràs MR; Jevtic Z; Bagger FO; Seguin J; Sivalingam R; Bezerra MF; Louwagie A; Juge S; Nellas I; Ivanek R; Tzankov A; Moll UM; Cantillo O; Schulz-Heddergott R; Fagnan A; Mercher T; Schwaller J
    Blood; 2023 May; 141(18):2245-2260. PubMed ID: 36735909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel t(1;8)(p31.3;q21.3) NFIA-RUNX1T1 Translocation in an Infant Erythroblastic Sarcoma.
    King RL; Siaghani PJ; Wong K; Edlefsen K; Shane L; Howard MT; Reichard KK; Mai M; Viswanatha DS; Greipp PT; Goble TA; Ruiz M; Hara H
    Am J Clin Pathol; 2021 Jun; 156(1):129-138. PubMed ID: 33313700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of transcriptional corepressor ETO2 in erythroid cells.
    Fujiwara T; Alqadi YW; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Harigae H
    Exp Hematol; 2013 Mar; 41(3):303-15.e1. PubMed ID: 23127762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
    Fagnan A; Bagger FO; Piqué-Borràs MR; Ignacimouttou C; Caulier A; Lopez CK; Robert E; Uzan B; Gelsi-Boyer V; Aid Z; Thirant C; Moll U; Tauchmann S; Kurtovic-Kozaric A; Maciejewski J; Dierks C; Spinelli O; Salmoiraghi S; Pabst T; Shimoda K; Deleuze V; Lapillonne H; Sweeney C; De Mas V; Leite B; Kadri Z; Malinge S; de Botton S; Micol JB; Kile B; Carmichael CL; Iacobucci I; Mullighan CG; Carroll M; Valent P; Bernard OA; Delabesse E; Vyas P; Birnbaum D; Anguita E; Garçon L; Soler E; Schwaller J; Mercher T
    Blood; 2020 Aug; 136(6):698-714. PubMed ID: 32350520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput sequencing identifies an NFIA/CBFA2T3 fusion gene in acute erythroid leukemia with t(1;16)(p31;q24).
    Micci F; Thorsen J; Panagopoulos I; Nyquist KB; Zeller B; Tierens A; Heim S
    Leukemia; 2013 Apr; 27(4):980-2. PubMed ID: 23032695
    [No Abstract]   [Full Text] [Related]  

  • 6. NFIA-ETO2, TP53, and erythroid leukemogenesis.
    Huang BJ; Shannon K
    Blood; 2023 May; 141(18):2168-2170. PubMed ID: 37140954
    [No Abstract]   [Full Text] [Related]  

  • 7. Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia.
    Leonards K; Almosailleakh M; Tauchmann S; Bagger FO; Thirant C; Juge S; Bock T; Méreau H; Bezerra MF; Tzankov A; Ivanek R; Losson R; Peters AHFM; Mercher T; Schwaller J
    Nat Commun; 2020 Jun; 11(1):2807. PubMed ID: 32533074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors.
    Cai Y; Xu Z; Xie J; Ham AJ; Koury MJ; Hiebert SW; Brandt SJ
    Biochem Biophys Res Commun; 2009 Dec; 390(2):295-301. PubMed ID: 19799863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Deazaneplanocin A (DZNep), an inhibitor of S-adenosylmethionine-dependent methyltransferase, promotes erythroid differentiation.
    Fujiwara T; Saitoh H; Inoue A; Kobayashi M; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Harigae H
    J Biol Chem; 2014 Mar; 289(12):8121-34. PubMed ID: 24492606
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Liu H; Guinipero TL; Schieffer KM; Carter C; Colace S; Leonard JR; Orr BA; Kahwash SB; Brennan PJ; Fitch JR; Kelly B; Magrini VJ; White P; Wilson RK; Mardis ER; Cottrell CE; Boué DR
    Haematologica; 2020 Apr; 105(4):e194-e197. PubMed ID: 31949013
    [No Abstract]   [Full Text] [Related]  

  • 11. Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy.
    Wagner K; Zhang P; Rosenbauer F; Drescher B; Kobayashi S; Radomska HS; Kutok JL; Gilliland DG; Krauter J; Tenen DG
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6338-43. PubMed ID: 16606850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryonic erythropoiesis and hemoglobin switching require transcriptional repressor ETO2 to modulate chromatin organization.
    Guo X; Plank-Bazinet J; Krivega I; Dale RK; Dean A
    Nucleic Acids Res; 2020 Oct; 48(18):10226-10240. PubMed ID: 32960220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions.
    Tauziède-Espariat A; Lew-Derivry L; Abbou S; Métais A; Pierron G; Reynaud S; Masliah-Planchon J; Mariet C; Hasty L; Dangouloff-Ros V; Boddaert N; Csanyi M; Aline-Fardin A; Lamaison C; Chrétien F; Beccaria K; Puget S; Varlet P
    Acta Neuropathol Commun; 2024 Jan; 12(1):12. PubMed ID: 38243303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of erythrocyte protein 4.2 gene expression during differentiation of murine erythroleukemia cells.
    Karacay B; Chang LS
    Genomics; 1999 Jul; 59(1):6-17. PubMed ID: 10395794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine erythroleukemia cells contain two distinct GATA-binding proteins that have different patterns of expression during cellular differentiation.
    Aumont FL; Trudel P; Wall L
    Differentiation; 1993 Jan; 52(2):169-76. PubMed ID: 8472887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ParaHox gene Cdx4 induces acute erythroid leukemia in mice.
    Thoene S; Mandal T; Vegi NM; Quintanilla-Martinez L; Rösler R; Wiese S; Metzeler KH; Herold T; Haferlach T; Döhner K; Döhner H; Schwarzmüller L; Klingmüller U; Buske C; Rawat VPS; Feuring-Buske M
    Blood Adv; 2019 Nov; 3(22):3729-3739. PubMed ID: 31770439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The leukemia associated ETO nuclear repressor gene is regulated by the GATA-1 transcription factor in erythroid/megakaryocytic cells.
    Ajore R; Dhanda RS; Gullberg U; Olsson I
    BMC Mol Biol; 2010 May; 11():38. PubMed ID: 20487545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma.
    Chen KS; Bridges CR; Lynton Z; Lim JWC; Stringer BW; Rajagopal R; Wong KT; Ganesan D; Ariffin H; Day BW; Richards LJ; Bunt J
    J Neurooncol; 2020 Jan; 146(1):41-53. PubMed ID: 31760595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in mice.
    Gentner E; Vegi NM; Mulaw MA; Mandal T; Bamezai S; Claus R; Tasdogan A; Quintanilla-Martinez L; Grunenberg A; Döhner K; Döhner H; Bullinger L; Haferlach T; Buske C; Rawat VP; Feuring-Buske M
    Oncotarget; 2016 Dec; 7(52):86889-86901. PubMed ID: 27888632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioredoxin-interacting protein regulates the differentiation of murine erythroid precursors.
    Gasiorek JJ; Mikhael M; Garcia-Santos D; Hui ST; Ponka P; Blank V
    Exp Hematol; 2015 May; 43(5):393-403.e2. PubMed ID: 25600403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.